Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 ...

With immunotherapy increasingly making it out of the lab and into hospitals as a viable way to treat serious conditions like ...

US Health and Human Services Secretary Robert F. Kennedy Jr.’s recent move to replace a federal panel of vaccine advisers ...

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The global mRNA vaccines and RNAi therapeutics market size was US$ 707.9 million in 2021. The global mRNA vaccines and RNAi therapeutics market size is estimated to reach US$ 8210.2 million by 2030, ...

A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.